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Plasma cell Leukemia (PCL) is a rare disorder characterized 
by malignant proliferation of plasma cells in peripheral blood 
and bone marrow. There are two forms of PCL: the primary 
form occurring in patients without preceding multiple myeloma 
or monoclonal gammopathy of undetermined significance, 
and the secondary form arising as a leukemic transformation 
of multiple myeloma [1].
A 55 years old lady presented in hematology clinic with 
complaints of fever, cough and bone pains since last 8 
months. General physical examination was unremarkable 
except for pallor. Initial investigations showed hemoglobin: 
9.6 gm/dl, hematocrit: 27.6%, MCV: 88 fl, MCH: 27 pg, white 
blood cells: 11.5 x109/L and platelets: 356x109/L. Peripheral 
film showed normochromic normocytic anemia with marked 
rouleux formation. Diffuse infiltration with atypical and 
pleomorhic plasma cells was observed on subsequent bone 
marrow examination. Serum immunofixation showed IgG 
kappa monoclonal gammopathy. Serum IgG levels were 
56.6g/L and skeletal survey demonstrated multiple lytic 
lesions in the skull. Creatinine level at diagnosis was 
114mol/L and calcium was 2.5 mmol/L. Based on her 
clinico-pathological manifestations, a diagnosis of multiple 
myeloma (stage IIIA according to Durie and Salmon 
classification) was made and the patient was started on 
thalidomide and dexamethasone.
However, unable to tolerate the treatment due to fatigue 
and somnolence, she presented again with shortness of 
breath and productive cough in one month time. This time, 
her chest X-ray revealed left sided pleural effusion along with 
right sided hydropneumothorax. Hilar vascular congestion 
and a posterolateral erosive lesion in fifth right rib were also 
evident. (Figure 1). Subsequent pleural tap drained off 1200 
ml of fluid from each side. Pleural fluid analysis an exudative 
picture with numerous red cells with leukocyte count of 1900 
mm3 and pleural fluid cytology exhibited malignant plasma 
cells. (Figure 2). This was not secondary to a traumatic tap as 
most of the cells were plasma cells and the differential in the 
peripheral blood was quite different as described below. 
Immuno-histochemistry demonstrated CD 138 positive 
plasma cells (Figure 3). Complete blood counts showed Hb 
7.7 g/dl, WBC 10.1 x103 /L, Neutrophils 14%, Lymphocytes 
56%,Plasma cells 22%;Monocytes:8% and Eosinophils 0% 
and platelets 55x106/L. Peripheral film examination showed 
22% plasma cells consistent with transformation to plasma 
cell leukemia. Serum albumin was 2.3 g/dl at the time of 
pleural tap and no evidence of renal failure was present at the 
time of progression of disease. 
Patient was treated with one cycle of thalidomide (reduced 
dosage at 100 mg/day) and dexamethasone as she refused 
for more aggressive chemotherapy and was discharged on 
this treatment but was lost to follow up.
PCL constitutes 2% to 4% of all cases of plasma cell 
disorders. The WHO criterion for diagnosis of PCL is that 
plasma cells constitute more than 20% of cells in the 
peripheral blood with an absolute plasma cell count of more 
than 2,000 mm3 [2]. The primary form which arise de novo 
constitutes 60% of all cases while secondary type represents 
leukemic transformation of myeloma. Overall response to 
treatment is poor with median survival of less than one year. 
Pleural fluid plasmacytosis in association with plasma cell 
leukaemia has been reported infrequently in literature [3, 4]. 
Review of local literature also revealed few cases of plasma 
cell leukaemia [5,6].
135 Images in HematologyOur patient was initially diagnosed with multiple myeloma; 
however she transformed to plasma cell leukaemia and also 
developed pleural fluid plasmacytosis. Pleural fluid 
plamacytosis seems to be an expression of this aggressive 
disease with poor outcome in most case reports and case 
series despite treatment.
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Figure 1. CD 138 on pleural fluid
Figure 2. Chest X ray 
Figure 3. Pleural fluid plasmacytosis
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